drug discovery News

CHI and Bio-IT World's "Structure-Based Design" Conference to be held on June 8-10, 2011 in Cambridge, MA, will feature a new session: New Targets and Drug Modalities

A US drug discovery company has found a single instrument that meets all its requirements for radio TLC scanning and radio HPLC detection - the dual-system Scan-RAM 1B from LabLogic Systems.

CHI and Bio-IT World's "Structure-Based Design" Conference to be held on June 8-10, 2011 in Cambridge, MA, will feature a new session: Protein Flexibility and Druggability

Euroscreen S.A., a pre-clinical drug discovery company based in Gosselies, Belgium, has chosen Tecan’s flexible Infinite® F200 PRO multimode plate reader for a variety of screening applications in drug discovery and characterization.

Promising Assays and Technologies for Better Pre-Clinical Predictions

“Intense” just might be the best term to describe the biotech industry’s pursuit of novel biomarkers for new drug discovery and development efforts

350 Speaker presentations are available on CD from Cambridge Healthtech Institute’s past event, Molecular Med TRI-CON, which took place on February 23-25, 2011 in San Francisco, CA (www.TriConference.com)

Featuring Keynote from the President’s Council of Advisors on Science and Technology Dr. David E. Shaw and Other Internationally Recognized Experts

Patented algorithm enables new optical diagnostic tools for disease detection...

BioAtla and Charles River have partnered to create an integrated biological service for antibodies and other protein therapeutics designed to accelerate drug development for customers from the earliest stages of discovery all the way through IND.

Oncology is the Key Therapeutic Segment of the Early Stage Drug Pipeline

Deadline for submissions is February 4, 2011

Nuclear Receptors: The Pipeline Outlook Report

The Laboratory Robotics Interest Group (LRIG) is pleased to announce its participation in LabAutomation2011, January 29 - February 2, 2011, Palm Springs Convention Center, Palm Springs, California.

AVOT has signed an option agreement to acquire two claim blocks in townships of Mekinac and Lajuene, Province of Quebec.

Enzo Life Sciences develops, produces and markets proprietary labeling and detection products for gene sequencing, genetic analysis and immunological research, among others. Its catalog of over 30,000 products serves the molecular biology etc.

VoIP industry is fast augmenting and hence it assures a definite hike in the revenue generation to any organisation that steps into this field.

Enzo Life Sciences, benefiting from increased emphasis on higher margin products, realized a greater than 100% gain in operating income.

New study indicates that tRNA-based drug discovery technology selects anti-HIV bioactive compounds possessing novel antiviral action...

Assays based on inhibition of tRNA receive $375,000 in funding...

Advinus is poised to give the world first blocbuster molecule drug discovery research says dr rashmi barbhaiya

CYTOO Cell Architects today announced the commercial release of CYTOOplates™ 96 that bring robustness, sensitivity and powerful quantification to cell-based assays and High Content Screening.

Bio-IT World is announcing its 2011 Best Practices Awards program and is opening the call for entries.

TCG Lifesciences, Ltd (“TCGLS”) of India and Carna Biosciences, Inc (“CarnaBio”) of Japan have entered into a strategic alliance to collaborate and provide jointly, high end drug discovery services.

Cambridge Healthtech Institute, a premier information provider for the life sciences industry, will host its Eighth International Discovery on Target meeting on November 2-4, 2010 in Boston, Massachusetts.

Overbrook Scientific, Inc., an independent instrumentation company, announces Total AIQ, its novel, multi-vendor, harmonized analytical instrumentation qualification (AIQ) service for GLP and cGMP regulatory compliance, and lower operational costs.

Leading Professionals From Pharmaceutical and Biotechnology Companies Examine Advancements in Genomic Research

G-Protein-Coupled Receptors are the largest gene families in the human genome and, rightfully so, have become the leading molecular target in 2008.

10th September 2010, Millenium Gloucester Hotel, London, UK A CPD accredited SMi Pharma-Masterclass focusing on various issues concerning Data Management in Medical Imaging

The Breaking Through Real World Storage Barriers in Next Generation Sequencing White Paper is Now Available

The Bio-IT World July/August 2010 issue is now available and can be found online at Bio-ITWorld.com.

Niche CRO moves its clinical and medical diagnostic labs to Bucks County, PA

The Specialty Pharmaceuticals Market Outlook reveals market dynamics, leading players and key therapy areas of opportunity for specialty pharma companies.

Ubiquitin Conference 2010 is a Meeting of Minds from Industry and Academia

Ubiquitin Conference 2010 is a Meeting of Minds from Industry and Academia

It presents viewpoints from both customers and suppliers. Segments, size, and growth of the market are presented. The trend toward the increased use of offshore suppliers is covered in detail.

More than 15 professionals from leading pharmaceutical and biotechnology companies will discuss the newest trends in managing an ever growing compound library, while optimizing laboratory automation and adhering to the highest levels of quality.

CMDBioscience and Research foundation of SUNY on behalf of Stony Brook University today announce the notice of allowability for patent for affinity score a proprietary method for estimating protein-protein binding affinities.

World-renowned experts will focus on prioritizing prime disease targets for future assay development and new applications of the unique drug discovery technology...

MRC Technology, the UK Medical Research Council's drug discovery and commercialisation company, is implementing Science Warehouse's e-procurement catalogue

Rising Financial and Regulatory Pressures on Western Pharma will Continue to Drive the Drug Discovery Research Market Growth in India and China

Bridge4Bio, an international business consultancy group focused on promoting the growth of life sciences and biotech companies, is targeting 4 strategic areas to assist both startups and established companies plan and grow their businesses globally.

Interview with: Malcolm Weir, Founder & CEO, Heptares Therapeutics

Hudson Robotics, Inc. today introduced the new VaryScreen™ ADME-Tox integrated workstation for faster, accurate and more efficient profiling of the absorption, distribution, metabolism and excretion (ADME) properties of drug molecules.

Selvita Ltd. presents recent developments on the company's investigational compounds during the AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics, in Boston, USA.

Trana Discovery and Southern Research Institute today announced that several bioactive hits from a set of 15,000 diverse small molecule compounds screened under contract with the NIAID exhibit antiviral activity against HIV-1 infected cells.

CIA2009, held alongside the Industrial Bus and Wireless Technology Conference, returns as Asia’s leading event for process engineering technology & process control, automation, instrumentation, analytical & laboratory technology and services.

GenScript expands its drug discovery services to assay development.

CYTOO SA, a provider of innovative enabling technologies for high content cell analysis, premiered what it believes is the world's first commercially available portfolio of cell adhesive micropattern products to the cell biology research community.

The conference is in session from October 1-2, 2009 in Lisbon, Portugal with topics ranging from how to decrease the cost of drug discovery to translational research.